Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary ImmunodeficienciesRelease Date:Education Hospital USA Knowledge Gaps in the Prevention of COVID-19 in EuropeRelease Date:Education Vaccines All Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary TeamsRelease Date:Education Rare Disease USA Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer PatientsQuality Improvement Oncology USA Educational Projects for Healthcare Professionals to Promote Cancer Patient SupportRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Menopause and Mental HealthRelease Date:Education Internal Medicine USA Latin America Needs Assessment of Prostate CancerRelease Date:Education Oncology All Efforts to Promote an Environmental Improvement for Cancer Genomic MedicineRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer TreatmentRelease Date:Education Oncology Japan Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal diseaseRelease Date:Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)Release Date:Education Internal Medicine All